{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:50Z","timestamp":1791685430982,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11596-023-2792-8","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T15:01:31Z","timestamp":1699110091000},"page":"1084-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["P25\/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice"],"prefix":"10.1007","volume":"43","author":[{"given":"Jing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-kang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-ji","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"issue":"10","key":"2792_CR1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1212\/WNL.44.10.1885","volume":"44","author":"TK Tatemichi","year":"1994","unstructured":"Tatemichi TK, Paik M, Bagiella E, et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology, 1994,44(10):1885\u20131891","journal-title":"Neurology"},{"issue":"9","key":"2792_CR2","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/01.STR.23.9.1225","volume":"23","author":"C Loeb","year":"1992","unstructured":"Loeb C, Gandolfo C, Croce R, et al. Dementia associated with lacunar infarction. Stroke, 1992,23(9):1225\u20131229","journal-title":"Stroke"},{"issue":"Pt12","key":"2792_CR3","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1093\/brain\/awr273","volume":"134","author":"LM Allan","year":"2011","unstructured":"Allan LM, Rowan EN, Firbank MJ, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain, 2011,134(Pt 12):3716\u20133727","journal-title":"Brain"},{"issue":"6","key":"2792_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1212\/WNL.42.6.1185","volume":"42","author":"TK Tatemichi","year":"1992","unstructured":"Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology, 1992,42(6):1185\u20131193","journal-title":"Neurology"},{"issue":"5","key":"2792_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1179\/1074935714Z.0000000013","volume":"22","author":"Y Fride","year":"2015","unstructured":"Fride Y, Adamit T, Maeir A, et al. What are the correlates of cognition and participation to return to work after first ever mild stroke?. Top Stroke Rehabil, 2015,22(5):317\u2013325","journal-title":"Top Stroke Rehabil"},{"issue":"1","key":"2792_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovic","year":"2017","unstructured":"Mijajlovic MD, Pavlovic A, Brainin M, et al. Post-stroke dementia - a comprehensive review. BMC Med, 2017,15(1):11","journal-title":"BMC Med"},{"issue":"2","key":"2792_CR7","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dore S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol, 2019,316(2):C135\u2013C153","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"2792_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neuropharm.2008.01.005","volume":"55","author":"KP Doyle","year":"2008","unstructured":"Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology, 2008,55(3):310\u2013318","journal-title":"Neuropharmacology"},{"issue":"1","key":"2792_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener, 2021,10(1):45","journal-title":"Transl Neurodegener"},{"key":"2792_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/bse0560111","volume":"56","author":"JZ Wang","year":"2014","unstructured":"Wang JZ, Gao X, Wang ZH. The physiology and pathology of microtubule-associated protein tau. Essays Biochem, 2014, 56: 111\u2013123","journal-title":"Essays Biochem"},{"issue":"12","key":"2792_CR11","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","volume":"91","author":"AC Alonso","year":"1994","unstructured":"Alonso AC, Zaidi T, Grundke-Iqbal I, et al. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA, 1994,91(12):5562\u20135566","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2792_CR12","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1073\/pnas.1916895117","volume":"117","author":"T Sen","year":"2020","unstructured":"Sen T, Saha P, Jiang T, et al. Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3beta in Alzheimer\u2019s disease. Proc Natl Acad Sci USA, 2020,117(8):4418\u20134427","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2792_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration. Neuron, 2010,68(6):1067\u20131081","journal-title":"Neuron"},{"issue":"1","key":"2792_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","volume":"28","author":"PC Pao","year":"2021","unstructured":"Pao PC, Tsai LH. Three decades of Cdk5. J Biomed Sci, 2021,28(1):79","journal-title":"J Biomed Sci"},{"key":"2792_CR15","doi-asserted-by":"publisher","first-page":"951202","DOI":"10.3389\/fncel.2022.951202","volume":"16","author":"C Ao","year":"2022","unstructured":"Ao C, Li C, Chen J, et al. The role of Cdk5 in neurological disorders. Front Cell Neurosci, 2022, 16: 951202","journal-title":"Front Cell Neurosci"},{"issue":"6762","key":"2792_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/45159","volume":"402","author":"GN Patrick","year":"1999","unstructured":"Patrick GN, Zukerberg L, Nikolic M, et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature, 1999,402(6762):615\u2013622","journal-title":"Nature"},{"issue":"6784","key":"2792_CR17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/35012636","volume":"405","author":"M S Lee","year":"2000","unstructured":"Lee M S, Kwon Y T, Li M, et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature, 2000,405(6784):360\u2013364","journal-title":"Nature"},{"issue":"10","key":"2792_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/35096019","volume":"2","author":"R Dhavan","year":"2001","unstructured":"Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol, 2001,2(10):749\u2013759","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2792_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2006.02.024","volume":"50","author":"ZH Cheung","year":"2006","unstructured":"Cheung ZH, Fu AKY, Ip NY. Synaptic roles of Cdk5: Implications in higher cognitive functions and neurodegenerative diseases. Neuron, 2006,50(1):13\u201318","journal-title":"Neuron"},{"issue":"2","key":"2792_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1471-4159.1993.tb03173.x","volume":"60","author":"M Arioka","year":"1993","unstructured":"Arioka M, Tsukamoto M, Ishiguro K, et al. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J Neurochem, 1993,60(2):461\u2013468","journal-title":"J Neurochem"},{"key":"2792_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","volume":"7","author":"T Kimura","year":"2014","unstructured":"Kimura T, Ishiguro K, Hisanaga S. Physiological and pathological phosphorylation of tau by Cdk5. Front Mol Neurosci, 2014, 7: 65","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"2792_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.arcmed.2012.10.015","volume":"43","author":"V Shukla","year":"2012","unstructured":"Shukla V, Skuntz S, Pant HC. Deregulated Cdk5 Activity Is Involved in Inducing Alzheimer\u2019s Disease. Arch Med Res, 2012,43(8):655\u2013662","journal-title":"Arch Med Res"},{"issue":"11","key":"2792_CR23","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/mp.2017.171","volume":"22","author":"QZ Tuo","year":"2017","unstructured":"Tuo QZ, Lei P, Jackman KA, et al. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke. Mol Psychiatry, 2017,22(11):1520\u20131530","journal-title":"Mol Psychiatry"},{"key":"2792_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.metabol.2016.12.003","volume":"68","author":"DJ Li","year":"2017","unstructured":"Li DJ, Li YH, Yuan HB, et al. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1\/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism, 2017, 68: 31\u201342","journal-title":"Metabolism"},{"key":"2792_CR25","doi-asserted-by":"publisher","first-page":"147496","DOI":"10.1016\/j.brainres.2021.147496","volume":"1765","author":"T Kubota","year":"2021","unstructured":"Kubota T, Kirino Y. Age-dependent impairment of memory and neurofibrillary tangle formation and clearance in a mouse model of tauopathy. Brain Res, 2021, 1765: 147496","journal-title":"Brain Res"},{"issue":"46","key":"2792_CR26","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden M, Kotilinek L, Forster C, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci, 2005,25(46):10637\u201310647","journal-title":"J Neurosci"},{"issue":"3","key":"2792_CR27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.celrep.2018.12.085","volume":"26","author":"F Paonessa","year":"2019","unstructured":"Paonessa F, Evans LD, Solanki R, et al. Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia. Cell Reports, 2019,26(3):582\u2013593","journal-title":"Cell Reports"},{"issue":"10","key":"2792_CR28","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin MK, Vazquez-Rosa E, Koh Y, et al. Reducing acetylated tau is neuroprotective in brain injury. Cell, 2021,184(10):2715\u20132732","journal-title":"Cell"},{"issue":"1","key":"2792_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","volume":"25","author":"JZ Wang","year":"2007","unstructured":"Wang JZ, Grundke-Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci, 2007,25(1):59\u201368","journal-title":"Eur J Neurosci"},{"key":"2792_CR30","doi-asserted-by":"crossref","first-page":"352805","DOI":"10.4061\/2011\/352805","volume":"2011","author":"DP Hanger","year":"2011","unstructured":"Hanger DP, Noble W. Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int J Alzheimers Dis, 2011, 2011: 352805","journal-title":"Int J Alzheimers Dis"},{"issue":"2","key":"2792_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1471-4159.1995.65020732.x","volume":"65","author":"CX Gong","year":"1995","unstructured":"Gong CX, Shaikh S, Wang JZ, et al. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem, 1995,65(2):732\u2013738","journal-title":"J Neurochem"},{"issue":"13","key":"2792_CR32","doi-asserted-by":"publisher","first-page":"248187","DOI":"10.1242\/jcs.248187","volume":"134","author":"P Sandal","year":"2021","unstructured":"Sandal P, Jong CJ, Merrill RA, et al. Protein phosphatase 2A-structure, function and role in neurodevelopmental disorders. J Cell Sci, 2021,134(13):248187","journal-title":"J Cell Sci"},{"issue":"12","key":"2792_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(07)70291-0","volume":"6","author":"S Seshadri","year":"2007","unstructured":"Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol, 2007,6(12):1106\u20131114","journal-title":"Lancet Neurol"},{"issue":"3","key":"2792_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/oxfordjournals.aje.a010000","volume":"150","author":"S Kalmijn","year":"1999","unstructured":"Kalmijn S, Launer LJ, Lindemans J, et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol, 1999,150(3):283\u2013289","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2792_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archinternmed.2010.393","volume":"171","author":"M Rusanen","year":"2011","unstructured":"Rusanen M, Kivipelto M, Quesenberry CP, et al. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med, 2011,171(4):333\u2013339","journal-title":"Arch Intern Med"},{"issue":"4","key":"2792_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1073\/pnas.89.4.1345","volume":"89","author":"A Tamaoka","year":"1992","unstructured":"Tamaoka A, Kalaria RN, Lieberburg I, et al. Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. Proc Natl Acad Sci USA, 1992,89(4):1345\u20131349","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2792_CR37","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1177\/0271678X16668889","volume":"37","author":"H Fujii","year":"2017","unstructured":"Fujii H, Takahashi T, Mukai T, et al. Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer\u2019s disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau. J Cereb Blood Flow Metab, 2017,37(7):2441\u20132457","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2792_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, et al. Tau protein kinases: involvement in Alzheimer\u2019s disease. Ageing Res Rev, 2013,12(1):289\u2013309","journal-title":"Ageing Res Rev"},{"issue":"3","key":"2792_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med, 2009,15(3):112\u2013119","journal-title":"Trends Mol Med"},{"issue":"4","key":"2792_CR40","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3233\/JAD-191066","volume":"73","author":"YQ Liu","year":"2020","unstructured":"Liu YQ, Kong C, Gong L, et al. The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites. J Alzheimers Dis, 2020,73(4):1455\u20131466","journal-title":"J Alzheimers Dis"},{"key":"2792_CR41","doi-asserted-by":"crossref","unstructured":"Cai HY, Zhao ZY, Ni LH, et al. Structural and Functional Deficits in Patients with Poststroke Dementia: A Multimodal MRI Study. Neural Plast, 2021:3536234","DOI":"10.1155\/2021\/3536234"},{"issue":"9","key":"2792_CR42","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1097\/HJH.0000000000002841","volume":"39","author":"NA Hilkens","year":"2021","unstructured":"Hilkens NA, Klijn CJM, Richard E. Blood pressure, blood pressure variability and the risk of poststroke dementia. J Hypertens, 2021,39(9):1859\u20131864","journal-title":"J Hypertens"},{"issue":"11","key":"2792_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","volume":"8","author":"ST Pendlebury","year":"2009","unstructured":"Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol, 2009,8(11):1006\u20131018","journal-title":"Lancet Neurol"},{"issue":"4","key":"2792_CR44","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/STROKEAHA.117.018529","volume":"49","author":"DA Levine","year":"2018","unstructured":"Levine DA, Galecki AT, Langa KM, et al. Risk Factors for Poststroke Cognitive Decline: The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke). Stroke, 2018,49(4):987\u2013994","journal-title":"Stroke"},{"issue":"1","key":"2792_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jama.2015.6968","volume":"314","author":"DA Levine","year":"2015","unstructured":"Levine DA, Galecki AT, Langa KM, et al. Trajectory of Cognitive Decline After Incident Stroke. JAMA, 2015,314(1):41\u201351","journal-title":"JAMA"},{"issue":"3","key":"2792_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1474-4422(12)70029-7","volume":"11","author":"A Pollock","year":"2012","unstructured":"Pollock A, St George B, Fenton M, et al. Top ten research priorities relating to life after stroke. Lancet Neurol, 2012,11(3):209\u2013209","journal-title":"Lancet Neurol"},{"issue":"1","key":"2792_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, et al. Tau protein phosphatases in Alzheimer\u2019s disease: The leading role of PP2A. Ageing Res Rev, 2013,12(1):39\u201349","journal-title":"Ageing Res Rev"},{"key":"2792_CR48","first-page":"22","volume":"8","author":"KN El","year":"2014","unstructured":"El KN, Gratuze M, Papon MA, et al. Insulin dysfunction and Tau pathology. Front Cell Neurosci, 2014, 8: 22","journal-title":"Front Cell Neurosci"},{"issue":"50","key":"2792_CR49","doi-asserted-by":"publisher","first-page":"13635","DOI":"10.1523\/JNEUROSCI.3949-07.2007","volume":"27","author":"E Planel","year":"2007","unstructured":"Planel E, Tatebayashi Y, Miyasaka T, et al. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci, 2007,27(50):13635\u201313648","journal-title":"J Neurosci"},{"key":"2792_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang NQ, Yan F, et al. Diabetes mellitus and Alzheimer\u2019s disease: GSK-3 beta as a potential link. Behav Brain Res, 2018, 339: 57\u201365","journal-title":"Behav Brain Res"},{"issue":"1","key":"2792_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, et al. Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes. J Pathol, 2011,225(1):54\u201362","journal-title":"J Pathol"},{"key":"2792_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fncel.2019.00017","volume":"13","author":"RA Goncalves","year":"2019","unstructured":"Goncalves RA, Wijesekara N, Fraser PE, et al. The Link Between Tau and Insulin Signaling: Implications for Alzheimer\u2019s Disease and Other Tauopathies. Front Cell Neurosci, 2019, 13: 17","journal-title":"Front Cell Neurosci"},{"key":"2792_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"LY Yang","year":"2018","unstructured":"Yang LY, Wang HY, Liu LJ, et al. The Role of Insulin\/IGF-1\/PI3K\/Akt\/GSK3 beta Signaling in Parkinson\u2019s Disease Dementia. Front Neurosci, 2018, 12: 73","journal-title":"Front Neurosci"},{"key":"2792_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fnins.2019.00629","volume":"13","author":"S Gabbouj","year":"2019","unstructured":"Gabbouj S, Ryhanen S, Marttinen M, et al. Altered Insulin Signaling in Alzheimer\u2019s Disease Brain - Special Emphasis on PI3K-Akt Pathway. Front Neurosci, 2019, 13: 629","journal-title":"Front Neurosci"},{"issue":"7","key":"2792_CR55","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1091\/mbc.e07-11-1106","volume":"19","author":"KH Sun","year":"2008","unstructured":"Sun KH, de Pablo Y, Vincent F, et al. Novel genetic tools reveal Cdk5\u2019s major role in Golgi fragmentation in Alzheimer\u2019s disease. Mol Biol Cell, 2008,19(7):3052\u20133069","journal-title":"Mol Biol Cell"},{"issue":"10","key":"2792_CR56","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.2174\/138955707782110114","volume":"7","author":"FY Wei","year":"2007","unstructured":"Wei FY, Tomizawa K. Cyclin-dependent kinase 5 (Cdk5): a potential therapeutic target for the treatment of neurodegenerative diseases and diabetes mellitus. Mini Rev Med Chem, 2007,7(10):1070\u20131074","journal-title":"Mini Rev Med Chem"},{"issue":"24","key":"2792_CR57","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4368-13.2014","volume":"34","author":"DA Meyer","year":"2014","unstructured":"Meyer DA, Torres-Altoro MI, Tan ZJ, et al. Ischemic Stroke Injury Is Mediated by Aberrant Cdk5. J Neurosci, 2014,34(24):8259\u20138267","journal-title":"J Neurosci"},{"issue":"23","key":"2792_CR58","doi-asserted-by":"publisher","first-page":"13650","DOI":"10.1073\/pnas.2232515100","volume":"100","author":"PD Smith","year":"2003","unstructured":"Smith PD, Crocker SJ, Jackson-Lewis V, et al. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA, 2003,100(23):13650\u201313655","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2792_CR59","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1177\/0271678X16662476","volume":"37","author":"JA Gutierrez-Vargas","year":"2017","unstructured":"Gutierrez-Vargas JA, Moreno H, Cardona-Gomez GP. Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity. J Cereb Blood Flow Metab, 2017,37(6):2208\u20132223","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-023-2792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-023-2792-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-023-2792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T11:13:06Z","timestamp":1730459586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-023-2792-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2792"],"URL":"https:\/\/doi.org\/10.1007\/s11596-023-2792-8","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}